Koala Health Secures Series B Funding to Revolutionize Chronic Pet Medication Delivery

Koala Health, a pet health company focused on simplifying the healthcare experience, announced the closing of a $20 million Series B funding round led by Valspring Capital.

“Koala Health is redefining the pet prescription experience by building a seamless bridge between veterinarians and pet parents,” said Yumin Choi of Valspring Capital. “By partnering directly with clinics and making it easier for pet owners to manage medications, Koala is creating a smarter, more efficient ecosystem that benefits everyone involved. It’s a modern solution to a long-overdue problem in veterinary care.”

For more information, read the full press release on Business Wire.